Resultado de búsqueda
Hace 2 días · Comunicado de prensa conjunto de Charité, BIH en Charité y el Centro Max Delbrück El mieloma múltiple es una de las formas más comunes de cáncer de las células inmunitarias en la médula ósea. Se considera incurable. Incluso cuando los pacientes responden al tratamiento al principio, el cáncer regresa. Para
Hace 1 día · The study was conducted in accordance with the Declaration of Helsinki and approved by the ethics committees of the participating clinics (Heinrich-Heine University Duesseldorf EA1/281/10, Charité Berlin EA1/144/21 and University Hospital Hannover 9741_BO_S_2021). All patients signed written informed consent before serum samples were acquired.
Hace 2 días · Charité - Universitätsmedizin Berlin Jul 1 2024 Multiple myeloma is one of the most common forms of cancer of the immune cells in the bone marrow. It is considered incurable.
Hace 2 días · 1 Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Center for Musculoskeletal Surgery, Berlin, Germany. 2 Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Julius Wolff Institute, Berlin, Germany.
Hace 2 días · Charité - Universitätsmedizin Berlin. "Multiple myeloma: Early detection of aggressive tumors." ScienceDaily. www.sciencedaily.com / releases / 2024 / 07 / 240701131804.htm (accessed July 1, 2024).
Hace 5 días · Multiple myeloma is one of the most common forms of cancer of the immune cells in the bone marrow. It is considered incurable. Even when patients respond to treatment at first, the cancer comes back. To be able to intervene faster and on a more targeted basis, researchers at Charité – Universitätsmedizin Berlin, the Berlin Institute of ...
Hace 2 días · Joint press release of Charité, BIH at Charité, and the Max Delbrück Center Multiple myeloma is one of the most common forms of cancer of the immune cells in the bone marrow.
